A comparative study on efficacy of amitriptyline and escitalopram in the treatment of depression

Simple item page
dc.contributor.authorAryal, Sushanten_US
dc.contributor.authorChakrabarti, Kajalen_US
dc.contributor.authorGupta, Mayurien_US
dc.date.accessioned2020-04-23T07:48:21Z
dc.date.available2020-04-23T07:48:21Z
dc.date.issued2018-02
dc.description.abstractBackground: Several generations of antidepressant medication which act by distinct pharmacological mechanisms have been introduced for the treatment of depression; tricyclic antidepressants (TCAs) were first line of treatment for many years. However, over the last decade, selective serotonin reuptake inhibitors (SSRIs) have displaced TCAs, mainly because of better side effect profile. There are no references in literature on comparison of efficacy of TCAs and SSRIs in Nepalese population. This study attempted to compare the efficacy of amitriptyline, a reference standard TCA with escitalopram, a newer SSRI in Nepalese population.Methods: An open level, randomised, prospective study was conducted for one year duration. Eighty outpatients suffering from major depression who met inclusion and exclusion criteria were randomly assigned to either amitriptyline or escitalopram group for four week study. Seventy one patients (amitriptyline N: 36, escitalopram N: 35) completed the study. Hamilton Depression Rating Scale (HDRS) was used to measure the antidepressant effect. Antidepressant efficacy was evaluated on reduction of HDRS score before and after therapy (End of four weeks).Results: In amitriptyline group, mean percentage reduction in HDRS score was 58.29% (13.5 points), while in escitalopram group was 60.78% (14.03 points). Both the drugs significantly improved the HDRS score at the end of the study (p<0.05). On intergroup comparison, antidepressant efficacy of amitriptyline and escitalopram did not differ significantly from each other (p>0.05).Conclusions: This study suggests that escitalopram is effective in the treatment of depression and its efficacy appears to be comparable to amitriptyline at the end of four weeks.en_US
dc.identifier.affiliationsDepartment of Pharmacology, Patan Academy of Health Sciences, Lalitpur, Nepalen_US
dc.identifier.affiliationsDepartment of Psychiatry, Nepal Medial College and Teaching Hospital Attarkhel, Jorpati, Kathmandu, Nepalen_US
dc.identifier.citationAryal Sushant, Chakrabarti Kajal, Gupta Mayuri. A comparative study on efficacy of amitriptyline and escitalopram in the treatment of depression. International Journal of Basic & Clinical Pharmacology. 2018 Feb; 7(2): 234-237en_US
dc.identifier.issn2319-2003
dc.identifier.issn2279-0780
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/199579
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber2en_US
dc.relation.volume7en_US
dc.source.urihttps://dx.doi.org/10.18203/2319-2003.ijbcp20180091en_US
dc.subjectAmitriptylineen_US
dc.subjectComparativeen_US
dc.subjectEscitalopramen_US
dc.subjectEfficacyen_US
dc.titleA comparative study on efficacy of amitriptyline and escitalopram in the treatment of depressionen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijbcp2018v7n2p234.pdf
Size:
335.1 KB
Format:
Adobe Portable Document Format
Download
Collections
International Journal of Basic & Clinical Pharmacology